Cargando…
Correction: Two-drug versus three-drug induction chemotherapy in pediatric acute myeloid leukemia: a randomized controlled trial
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515103/ https://www.ncbi.nlm.nih.gov/pubmed/36167799 http://dx.doi.org/10.1038/s41408-022-00735-0 |
| _version_ | 1784798419064193024 |
|---|---|
| author | Radhakrishnan, Venkatraman Bakhshi, Sameer Kayal, Smita Thampy, Cherian Batra, Ankit Shenoy, Praveen Kumar Kumar, Hemanth Rajaraman, Swaminathan Chaudhary, Shilpi Bisht, Reema Dubashi, Biswajit Ganesan, Trivadi S. |
| author_facet | Radhakrishnan, Venkatraman Bakhshi, Sameer Kayal, Smita Thampy, Cherian Batra, Ankit Shenoy, Praveen Kumar Kumar, Hemanth Rajaraman, Swaminathan Chaudhary, Shilpi Bisht, Reema Dubashi, Biswajit Ganesan, Trivadi S. |
| author_sort | Radhakrishnan, Venkatraman |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9515103 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-95151032022-09-29 Correction: Two-drug versus three-drug induction chemotherapy in pediatric acute myeloid leukemia: a randomized controlled trial Radhakrishnan, Venkatraman Bakhshi, Sameer Kayal, Smita Thampy, Cherian Batra, Ankit Shenoy, Praveen Kumar Kumar, Hemanth Rajaraman, Swaminathan Chaudhary, Shilpi Bisht, Reema Dubashi, Biswajit Ganesan, Trivadi S. Blood Cancer J Correction Nature Publishing Group UK 2022-09-27 /pmc/articles/PMC9515103/ /pubmed/36167799 http://dx.doi.org/10.1038/s41408-022-00735-0 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Correction Radhakrishnan, Venkatraman Bakhshi, Sameer Kayal, Smita Thampy, Cherian Batra, Ankit Shenoy, Praveen Kumar Kumar, Hemanth Rajaraman, Swaminathan Chaudhary, Shilpi Bisht, Reema Dubashi, Biswajit Ganesan, Trivadi S. Correction: Two-drug versus three-drug induction chemotherapy in pediatric acute myeloid leukemia: a randomized controlled trial |
| title | Correction: Two-drug versus three-drug induction chemotherapy in pediatric acute myeloid leukemia: a randomized controlled trial |
| title_full | Correction: Two-drug versus three-drug induction chemotherapy in pediatric acute myeloid leukemia: a randomized controlled trial |
| title_fullStr | Correction: Two-drug versus three-drug induction chemotherapy in pediatric acute myeloid leukemia: a randomized controlled trial |
| title_full_unstemmed | Correction: Two-drug versus three-drug induction chemotherapy in pediatric acute myeloid leukemia: a randomized controlled trial |
| title_short | Correction: Two-drug versus three-drug induction chemotherapy in pediatric acute myeloid leukemia: a randomized controlled trial |
| title_sort | correction: two-drug versus three-drug induction chemotherapy in pediatric acute myeloid leukemia: a randomized controlled trial |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515103/ https://www.ncbi.nlm.nih.gov/pubmed/36167799 http://dx.doi.org/10.1038/s41408-022-00735-0 |
| work_keys_str_mv | AT radhakrishnanvenkatraman correctiontwodrugversusthreedruginductionchemotherapyinpediatricacutemyeloidleukemiaarandomizedcontrolledtrial AT bakhshisameer correctiontwodrugversusthreedruginductionchemotherapyinpediatricacutemyeloidleukemiaarandomizedcontrolledtrial AT kayalsmita correctiontwodrugversusthreedruginductionchemotherapyinpediatricacutemyeloidleukemiaarandomizedcontrolledtrial AT thampycherian correctiontwodrugversusthreedruginductionchemotherapyinpediatricacutemyeloidleukemiaarandomizedcontrolledtrial AT batraankit correctiontwodrugversusthreedruginductionchemotherapyinpediatricacutemyeloidleukemiaarandomizedcontrolledtrial AT shenoypraveenkumar correctiontwodrugversusthreedruginductionchemotherapyinpediatricacutemyeloidleukemiaarandomizedcontrolledtrial AT kumarhemanth correctiontwodrugversusthreedruginductionchemotherapyinpediatricacutemyeloidleukemiaarandomizedcontrolledtrial AT rajaramanswaminathan correctiontwodrugversusthreedruginductionchemotherapyinpediatricacutemyeloidleukemiaarandomizedcontrolledtrial AT chaudharyshilpi correctiontwodrugversusthreedruginductionchemotherapyinpediatricacutemyeloidleukemiaarandomizedcontrolledtrial AT bishtreema correctiontwodrugversusthreedruginductionchemotherapyinpediatricacutemyeloidleukemiaarandomizedcontrolledtrial AT dubashibiswajit correctiontwodrugversusthreedruginductionchemotherapyinpediatricacutemyeloidleukemiaarandomizedcontrolledtrial AT ganesantrivadis correctiontwodrugversusthreedruginductionchemotherapyinpediatricacutemyeloidleukemiaarandomizedcontrolledtrial |